Skip to main content
OpenTrials

Clinical trial condition

Carcinoma

Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.

8,856 public trials 2,106 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma trial results

Completed

Study of Dalantercept in Patients With Squamous Cell Carcinoma of the Head and Neck

NCT01458392

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations
  • Acceleron Investigative Site Aurora, Colorado, United States
  • Acceleron Investigative Site Atlanta, Georgia, United States
  • Acceleron Investigative Site Boston, Massachusetts, United States
  • Acceleron Investigative Site Detroit, Michigan, United States
View Trial Details
Completed

Phase 2, Randomized, Double-Blind, Placebo-Controlled of the Efficacy and Safety of CF102 in Hepatocellular Carcinoma (HCC)

NCT02128958

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • Simmons Cancer Center Dallas, Texas, United States
  • Complex Oncology Center - Plovdiv Plovdiv, Bulgaria
  • Multiprofile Hospital for Active Treatment Central Onco Hospita Plovdiv, Bulgaria
View all 21 locations
View Trial Details
Completed

Testing the PD-1 Inhibitor Pembrolizumab as Maintenance Therapy After Initial Chemotherapy in Metastatic Bladder Cancer

NCT02500121

Conditions
Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +14 more
Locations
  • University of Arizona at Dignity Health St. Joseph's Phoenix, Arizona, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • University of Southern California Los Angeles, California, United States
  • Georgetown University Washington D.C., District of Columbia, United States
View all 28 locations
View Trial Details
Completed

Study of Rogaratinib (BAY1163877) vs Chemotherapy in Patients With FGFR (Fibroblast Growth Factor Receptor)-Positive Locally Advanced or Metastatic Urothelial Carcinoma

NCT03410693

Conditions
Carcinoma, Carcinoma, Transitional Cell, Neoplasms, +2 more
Locations
  • Alaska Clinical Research Center, LLC Anchorage, Alaska, United States
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • University of Southern California Los Angeles, California, United States
  • UC Davis Comprehensive Cancer Center Sacramento, California, United States
View all 161 locations
View Trial Details
Completed

A Study Exploring the Safety and Efficacy of INCAGN01949 in Combination With Immune Therapies in Advanced or Metastatic Malignancies

NCT03241173

Conditions
Adenocarcinoma, Adenoma, Adnexal Diseases, +74 more
Locations
  • The University of Alabama Birmingham (UAB) Birmingham, Alabama, United States
  • Scottsdale Healthcare Hospitals DBA HonorHealth Scottsdale, Arizona, United States
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • Mount Sinai Medical Center of Florida, Inc. Miami, Florida, United States
View all 15 locations
View Trial Details

Related conditions